ArticleJournal of medicinal chemistry2013

Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.

Puranik Purushottamachar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.